COR · 8-K · 20260805PR000032

Market Demand Trends

Cencora, Inc. · 2026-08-05 · Importance 49 · Surprise 32

U.S. Healthcare Solutions revenue increased 4.9% to $74.9 billion, primarily reflecting overall market growth driven by unit volume. Demand was strongest for specialty products sold to health systems and physician practices and for GLP-1 products labeled for diabetes and/or weight loss. Growth was partly offset by lower manufacturer prices for certain branded pharmaceuticals, the 2025 loss of an oncology customer, and lower sales to a large mail-order customer.